Trends in consent for clinical trials in cardiovascular disease

Journal of the American Heart Association

Volumn 5, Issue 6, 2016, Pages

  Kerkhoff, Louis A ^a   Butler, Javed ^b   Kelkar, Anita A ^c   Shore, Supriya ^c   Speight, Candace D ^c   Wall, Louisa K ^c   Dickert, Neal W ^c,d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

Clinical trial; Informed consent; Recruitment; Research ethics; Trials

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; HUMAN; INFORMED CONSENT; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT REFUSAL; TREND STUDY; ETHICS; PATIENT ATTITUDE; PATIENT SELECTION; RESEARCH ETHICS; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

CARDIOVASCULAR DISEASES; ETHICS, RESEARCH; HUMANS; INFORMED CONSENT; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 85006190074     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.003582     Document Type: Article

References (16)

1. Scoggins JF, Ramsey SD. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. J Natl Cancer Inst. 2010;102:1371.
2. Gheorghiade M, Vaduganathan M, Greene SJ, Mentz RJ, Adams KF Jr, Anker SD, Arnold M, Baschiera F, Cleland JG, Cotter G, Fonarow GC, Giordano C, Metra M, Misselwitz F, Mühlhofer E, Nodari S, Frank Peacock W, Pieske BM, Sabbah HN, Sato N, Shah MR, Stockbridge NL, Teerlink JR, van Veldhuisen DJ, Zalewski A, Zannad F, Butler J. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. Heart Fail Rev. 2014;19:135-152.
3. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366:1859-1869.
4. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, CaliffRM, Schulman KA. Ethical and scientific implications of the globalization of clinical research. N Engl J Med. 2009;360:816-823.
5. Butler J, Fonarow GC, O'Connor C, Adams K, Bonow RO, Cody RJ, Collins SP, Dunnmon P, Dinh W, Fiuzat M, Georgiopoulou VV, Grant S, Kim SY, Kupfer S, Lefkowitz M, Mentz RJ, Misselwitz F, Pitt B, Roessig L, Schelbert E, Shah M, Solomon S, Stockbridge N, Yancy C, Gheorghiade M. Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators. Am Heart J. 2015;169:305-314.
6. Martin SS, Ou FS, Newby LK, Sutton V, Adams P, Felker GM, Wang TY. Patientand trial-specific barriers to participation in cardiovascular randomized clinical trials. J Am Coll Cardiol. 2013;61:762-769.
7. Butler J, Tahhan AS, Georgiopoulou VV, Kelkar A, Lee M, Khan B, Peterson E, Fonarow GC, Kalogeropoulos AP, Gheorghiade M. Trends in characteristics of cardiovascular clinical trials 2001-2012. Am Heart J. 2015;170:263-272.e2.
8. Schulz KF, Altman DG, Moher D; Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18.
9. Cooke CR, Erickson SE, Watkins TR, Matthay MA, Hudson LD, Rubenfeld GD. Age-, sex-, and race-based differences among patients enrolled versus not enrolled in acute lung injury clinical trials. Crit Care Med. 2010;38:1450-1457.
10. St Germain D, DenicoffAM, Dimond EP, Carrigan A, Gonzalez MM, Wilkinson K, Mathiason MA, Duggan B, Einolf S, McCaskill-Stevens W, Bryant DM, Thompson MA, Grubbs SS, Go RS. Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual. J Oncol Pract. 2014;10:e73-e80.
11. Dickert NW, Fehr AE, Llanos A, Scicluna VM, Samady H. Patients' views of consent for research enrollment during acute myocardial infarction. Acute Card Care. 2015;17:1-4.
12. Gammelgaard A, Rossel P, Mortensen OS; DANAMI-2 Investigators. Patients' perceptions of informed consent in acute myocardial infarction research: a Danish study. Soc Sci Med. 2004;58:2313-2324.
13. Kim SY, Miller FG. Informed consent for pragmatic trials-the integrated consent model. N Engl J Med. 2014;370:769-772.
14. Cho MK, Magnus D, Constantine M, Lee SS, Kelley M, Alessi S, Korngiebel D, James C, Kuwana E, Gallagher TH, Diekema D, Capron AM, Joffe S, Wilfond BS. Attitudes toward risk and informed consent for research on medical practices: a cross-sectional survey. Ann Intern Med. 2015;162:690-696.
15. Nayak RK, Wendler D, Miller FG, Kim SY. Pragmatic randomized trials without standard informed consent? A national survey. Ann Intern Med. 2015;163:356-364.
16. Faden RR, Beauchamp TL, Kass NE. Informed consent, comparative effectiveness, and learning health care. N Engl J Med. 2014;370:766-768.